血液腫瘤科 arrow_r
       
形象圖1 形象圖2 形象圖3
醫療科相關疾病及症狀

惡性腫瘤、貧血、紫斑症、凝血異常、血友病、白血病等

提供各項檢查及治療服務

各類惡性腫瘤之治療,計畫擬定,化學治療,標靶治療,免疫治療,安寧緩和醫療

未來發展

本科在各癌別多專科醫療團隊、癌症專科病房護理師、分子醫學實驗室、個管師、營養師、心理師、傷口照護師、緩和醫療中心等各科菁英的協助之下,全力發展以 病人為中心的舒適醫療 ,結合專業、溝通、家庭及社會資源,在抗癌的過程中一起與病人奮鬥,努力減少身心的不適,為 病人及家庭提供最貼心的照顧

01 台灣健康照護聯合國際學術研討會-海報競賽組【入選】血液腫瘤科、門診護理站(態極圈)、癌症中心、護理部 (主題:改善門診癌症病人因化學治療所致周邊神經病變之成效)
02 薛爾榮 等(2021)。Effects of yoga on improving quality of life in patients with breast cancer: a meta‑analysis of randomized controlled trials. Breast Cancer, 2021; published online
03 黃冠誠 等(2020)。Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma. Pleura and Peritoneum,; 2020, published online.
04 黃冠誠 等(2020)。Pterostilbene Sensitizes Cisplatin-Resistant Human Bladder Cancer Cells with Oncogenic HRAS. Cancers, 2020; 12(2869): -.
05 黃冠誠 等(2019)。Curcumin functions as a MEK inhibitor to induce a synthetic lethal effect on KRAS mutant colorectal cancer cells receiving targeted drug regorafenib. Journal of Nutritional Biochemistry, 2019; published online.
06 黃冠誠 等(2019)。SECONDARY METABOLITES FROM THE FLOWERS OF Michelia crassipe. Chemistry of Natural Compounds’ 2019; 55(5): 982-983.
07 黃冠誠 等(2019)。SECONDARY METABOLITES FROM THE LEAVES OF Elaeagnus glabra. Chemistry of Natural Compounds, 2019; 55(4): 724-725
08 黃冠誠 等(2019)。Elucidation of the Effects of Si-Wu Tang on Menstrual Disorder Patterns through Activation of Aromatase and Antioxidation. Evidence-Based Complementary and Alternative Medicine, 2019; 29: published online
09 黃冠誠 等(2019)。SECONDARY METABOLITES FROM THE LEAVES OF Michelia fuscata. Chemistry of Natural Compounds, 2019; 55(1): 183-185
10 黃冠誠 等(2018)。A NEW PHENYLALKANOID FROM THE RHIZOMES OF Alpinia galangal. Chemistry of Natural Compounds, 2018; 54(6): 1072-1075
11 黃冠誠 等(2018)。A NEW DIPHENYL ETHER FROM Cinnamomum subavenium. Chemistry of Natural Compounds, 2018; 54(5): 869-871